Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Retrospective review of genomic testing in breast cancer: Does it improve outcome?

Breast cancer research and treatment - 1 May 2017

Gastelum Grady M, Iqbal Cyrus, Hilsenbeck Susan G, Rimawi Mothaffar F, Niravath Polly

Abstract excerpt

PURPOSE: Tumor genomic testing has become widely available in many clinical settings. However, we do not yet understand how to best harness the information yielded from this testing. We retrospectively investigated the clinical courses of 24 patients who underwent tumor genomic testing to determine whether targeted therapy is associated with improved progression free survival (PFS) compared to standard therapy....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Breast Neoplasms
Share to Disease-Free Survival

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Testing

Share to Genomics

Share to Kaplan-Meier Estimate

Share to Molecular Targeted Therapy

Share to Treatment Outcome

Source

Identifiers

PMID: 28224382
DOI: 10.1007/s10549-017-4154-3

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Retrospective review of genomic testing in breast cancer: Does it improve outcome?PMID 28224382Read ↗

Clinical implications of breast cancer tumor genomic testing.Semantic proximity Read ↗

Impact of tissue-based genomic profiling on clinical decision making in the management of patients with metastatic breast cancer at academic centers.Semantic proximity Read ↗

Precision medicine in breast cancer: genes, genomes, and the future of genomically driven treatments.Semantic proximity Read ↗

Assessment of a cancer genomic profile test for patients with metastatic breast cancer.Semantic proximity Read ↗

Genetic Testing Enhances the Precision Diagnosis and Treatment of Breast Cancer.Semantic proximity Read ↗

Initial assessment of a cancer genomic profile test for patients with metastatic breast cancer: a retrospective studySemantic proximity Read ↗

Molecular Pathology of Breast Tumors: Diagnostic and Actionable Genetic Alterations.Semantic proximity Read ↗

Molecular Pathology of Breast Tumors: Diagnostic and Actionable Genetic Alterations.Semantic proximity Read ↗

Molecular Testing in Breast Cancer: A Guide to Current Practices.Semantic proximity Read ↗

Association of Germline Genetic Testing Results With Locoregional and Systemic Therapy in Patients With Breast Cancer.Semantic proximity Read ↗

Tumor Tissue- versus Plasma-based Genotyping for Selection of Matched Therapy and Impact on Clinical Outcomes in Patients with Metastatic Breast Cancer.Semantic proximity Read ↗

Genomics to select treatment for patients with metastatic breast cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.